Shared Decision-Making for Older Breast Cancer Survivors

Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study

Recruiting Phase 2 Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
80 and older
Sex
Female
Trial phase
Phase 2
Study type
Interventional
Purpose
Health Services Research
Participants needed
364 (estimated)
Sponsor
Dana-Farber Cancer Institute · Other
Who this trial is looking for

This trial is looking for older women aged 80 and above who have been treated for breast cancer. Participants will help evaluate a toolkit designed to support them in making informed decisions about their mammogram screenings.

Are You a Good Fit for This Trial?
Rules you out PregnancyYoung patientsPrison population

You may be able to join if

  • I am 80 years old or older.
  • I have a history of stage 0-III breast cancer.
  • I have no current breast cancer or recent breast cancer recurrence.
  • I have at least one intact breast.
  • I have had a mammogram in the last 24 months.
  • I have had at least 12 months since my most recent breast surgery.
  • I can take surveys.
  • I receive some of my oncology care at a participating site.

You may not be able to join if

  • I cannot provide informed consent.
  • I was assigned male at birth.
  • I have breast imaging findings that need further testing.
  • I have previously stopped getting mammograms.
  • I have a history of atypical ductal hyperplasia or non-pleomorphic LCIS.
  • I have metastatic breast cancer.
  • I am in hospice care.
  • My clinician is not willing to participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study evaluates the effectiveness of a Shared Decision-Making (SDM) toolkit designed to support older breast cancer survivors aged 80 and above in making informed decisions about continuing surveillance mammography.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Participant Inclusion Criteria: * Women aged ≥ 80 years at the time of registration * History of stage 0-III breast cancer (Of note: ductal carcinoma in situ \[DCIS\], pleomorphic lobular carcinoma in situ \[because it is typically treated like DCIS\], or invasive breast cancer of any subtype are a…
Contacts

Rachel Freedman, MD, MPH

617-632-4587

Rachel_freedman@dfci.harvard.edu

CONTACT